Literature DB >> 18021073

Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex.

Heidi Mendoza1, David G Campbell, Kerry Burness, James Hastie, Natalia Ronkina, Jae-Hyuck Shim, J Simon C Arthur, Roger J Davis, Matthias Gaestel, Gary L Johnson, Sankar Ghosh, Philip Cohen.   

Abstract

The protein kinase TAK1 (transforming growth factor-beta-activated kinase 1), which has been implicated in the activation of MAPK (mitogen-activated protein kinase) cascades and the production of inflammatory mediators by LPS (lipopolysaccharide), IL-1 (interleukin 1) and TNF (tumour necrosis factor), comprises the catalytic subunit complexed to the regulatory subunits, termed TAB (TAK1-binding subunit) 1 and either TAB2 or TAB3. We have previously identified a feedback-control mechanism by which p38alpha MAPK down-regulates TAK1 and showed that p38alpha MAPK phosphorylates TAB1 at Ser(423) and Thr(431). In the present study, we identified two IL-1-stimulated phosphorylation sites on TAB2 (Ser(372) and Ser(524)) and three on TAB3 (Ser(60), Thr(404) and Ser(506)) in human IL-1R cells [HEK-293 (human embryonic kidney) cells that stably express the IL-1 receptor] and MEFs (mouse embryonic fibroblasts). Ser(372) and Ser(524) of TAB2 are not phosphorylated by pathways dependent on p38alpha/beta MAPKs, ERK1/2 (extracellular-signal-regulated kinase 1/2) and JNK1/2 (c-Jun N-terminal kinase 1/2). In contrast, Ser(60) and Thr(404) of TAB3 appear to be phosphorylated directly by p38alpha MAPK, whereas Ser(506) is phosphorylated by MAPKAP-K2/MAPKAP-K3 (MAPK-activated protein kinase 2 and 3), which are protein kinases activated by p38alpha MAPK. Studies using TAB1(-/-) MEFs indicate important roles for TAB1 in recruiting p38alpha MAPK to the TAK1 complex for the phosphorylation of TAB3 at Ser(60) and Thr(404) and in inhibiting the dephosphorylation of TAB3 at Ser(506). TAB1 is also required to induce TAK1 catalytic activity, since neither IL-1 nor TNFalpha was able to stimulate detectable TAK1 activity in TAB1(-/-) MEFs. Surprisingly, the IL-1 and TNFalpha-stimulated activation of MAPK cascades and IkappaB (inhibitor of nuclear factor kappaB) kinases were similar in TAB1(-/-), MEKK3(-/-) [MAPK/ERK (extracellular-signal-regulated kinase) kinase kinase 3] and wild-type MEFs, suggesting that another MAP3K (MAPK kinase kinase) may mediate the IL-1/TNFalpha-induced activation of these signalling pathways in TAB1(-/-) and MEKK3(-/-) MEFs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18021073     DOI: 10.1042/BJ20071149

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

Review 1.  Targeting innate immunity protein kinase signalling in inflammation.

Authors:  Matthias Gaestel; Alexey Kotlyarov; Michael Kracht
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

2.  TAK1-binding protein 1, TAB1, mediates osmotic stress-induced TAK1 activation but is dispensable for TAK1-mediated cytokine signaling.

Authors:  Maiko Inagaki; Emily Omori; Jae-Young Kim; Yoshihiro Komatsu; Greg Scott; Manas K Ray; Gen Yamada; Kunihiro Matsumoto; Yuji Mishina; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

3.  TLR2 and TLR4 signaling pathways are required for recombinant Brucella abortus BCSP31-induced cytokine production, functional upregulation of mouse macrophages, and the Th1 immune response in vivo and in vitro.

Authors:  Jia-Yun Li; Yuan Liu; Xiao-Xue Gao; Xiang Gao; Hong Cai
Journal:  Cell Mol Immunol       Date:  2014-04-28       Impact factor: 11.530

4.  TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells.

Authors:  Alfiya Safina; Paula Sotomayor; Michelle Limoge; Carl Morrison; Andrei V Bakin
Journal:  Mol Cancer Res       Date:  2011-06-23       Impact factor: 5.852

5.  A PTP4A3 peptide PIMAP39 modulates TNF-alpha levels and endotoxic shock.

Authors:  Xiaoren Tang; Timothy Woodward; Salomon Amar
Journal:  J Innate Immun       Date:  2009-08-20       Impact factor: 7.349

6.  Transforming growth factor beta-activated kinase 1 (TAK1) kinase adaptor, TAK1-binding protein 2, plays dual roles in TAK1 signaling by recruiting both an activator and an inhibitor of TAK1 kinase in tumor necrosis factor signaling pathway.

Authors:  Peter Broglie; Kunihiro Matsumoto; Shizuo Akira; David L Brautigan; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

7.  Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression.

Authors:  Yang Yu; Ningling Ge; Min Xie; Wenjing Sun; Susan Burlingame; Amy K Pass; Jed G Nuchtern; Dekai Zhang; Songbin Fu; Michael D Schneider; Jia Fan; Jianhua Yang
Journal:  J Biol Chem       Date:  2008-07-10       Impact factor: 5.157

8.  TAK1 targeting by glucocorticoids determines JNK and IkappaB regulation in Toll-like receptor-stimulated macrophages.

Authors:  Sandip Bhattacharyya; Christine K Ratajczak; Sherri K Vogt; Crystal Kelley; Marco Colonna; Robert D Schreiber; Louis J Muglia
Journal:  Blood       Date:  2010-01-11       Impact factor: 22.113

9.  S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway.

Authors:  So Yong Kim; Kyung-Hwa Baik; Kwan-Hyuck Baek; Kyong-Hwa Chah; Kyung Ah Kim; Gyuyoung Moon; Eunyu Jung; Seong-Tae Kim; Jae-Hyuck Shim; Matthew B Greenblatt; Eunyoung Chun; Ki-Young Lee
Journal:  Mol Cell Biol       Date:  2013-11-25       Impact factor: 4.272

10.  Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase.

Authors:  Mark Windheim; Margaret Stafford; Mark Peggie; Philip Cohen
Journal:  Mol Cell Biol       Date:  2008-01-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.